Eiffage S.A. : The trend should regain control
Entry price | Target | Stop-loss | Potential |
---|
€90.54 |
€100.5 |
€85.6 |
+11% |
---|
Eiffage's shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths● Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 86.27 support.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● The group usually releases upbeat results with huge surprise rates.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● The stock is in a well-established, long-term rising trend above the technical support level at 83.41 EUR
Weaknesses● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.